June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
The novelty of Toll like receptor-4 ligand and RGC degeneration
Author Affiliations & Notes
  • Yasunari Munemasa
    Ophthalmology, St Marianna University, Kawasaki, Japan
  • Kazuhide Takada
    Ophthalmology, St Marianna University, Kawasaki, Japan
  • Kaori Kojima
    Ophthalmology, St Marianna University, Kawasaki, Japan
  • Satoki Ueno
    Ophthalmology, St Marianna University, Kawasaki, Japan
  • Yasushi Kitaoka
    Ophthalmology, St Marianna University, Kawasaki, Japan
  • Footnotes
    Commercial Relationships Yasunari Munemasa, None; Kazuhide Takada, None; Kaori Kojima, None; Satoki Ueno, None; Yasushi Kitaoka, Kowa Company, Ltd. (F), Kowa Company, Ltd. (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2466. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yasunari Munemasa, Kazuhide Takada, Kaori Kojima, Satoki Ueno, Yasushi Kitaoka; The novelty of Toll like receptor-4 ligand and RGC degeneration. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2466.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Toll like receptor-4 (TLR-4) has been indicated in response to various ligands related with cell death signaling, in addition to autoimmune response. The purpose of this study is to investigate the novelty of TLR-4 in RGC degeneration.

Methods: Eight week male C3H/HeJ and C3H/HeN mice were used in this study. C3H/HeJ mice show dysfunction of TLR-4. In contrast, C3H/HeN mice show normal TLR-4 function. To generate optic nerve crush (ONC), the nerve of one eye was exposed and clamped approximately 0.5 mm from the globe with self-closing forceps for 10s, contralateral eye was used as a control. RGC was labeled with fluoro-gold at superior colliculus 5 days before ONC and morphological analysis was performed with whole mount retina at 2 weeks after ONC. Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry (MALDI-TOFMS) was used to detect TLR-4 ligands after immunoprecipitation with TLR-4 antibody and isolation of retinal membrane proteins at 5 days after ONC. Induction of RGC degeneration with TLR-4 ligand was studied with cell viability assay using RGC-5 cells and intravitreal injection of TLR-4 ligand on C3H/HeJ and C3H/HeN mice.

Results: A significant decrease in RGC was observed in the retina of C3H/HeJ mice compared to C3H/HeN mice 2 weeks after ONC (C3H/HeJ 0.24 fold / control vs C3H/HeN 0.40 fold / control, P < 0.05). MALDI-TOF MS identified Histone H2B type1-B (score129) as the ligand of TLR-4. Histone H2B induced RGC-5 cells death, 0.5 fold / control (P < 0.05). A decrease in RGC density was more apparent in the retina of C3H/HeN mice compared to C3H/HeJ mice at 7 days after intravitreal injection of Histone H2B.

Conclusions: Histone H2B was identified as a novelty of TLR-4 and induced RGC degeneration through TLR-4.

Keywords: 695 retinal degenerations: cell biology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×